AstraZeneca advances response to global COVID-19 challenge as it gets commitment for Oxford’s potential new vaccine
CAMBRIDGE, U.K. — AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organizations to make the University of Oxford’s vaccine widely accessible around the world in an equitable manner. The company has concluded the first agreements for at least 400 million doses and